Bright Green enters partnership with Benuvia Pharmaceuticals
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 15 2024
0mins
Supply Agreement: Bright Green has signed a letter of intent to supply DEA-approved marijuana extracts and plant-based psychedelics to Benuvia Operations, highlighting its commitment to providing high-quality organic materials for US pharmaceutical partners.
Compliance and Production: The agreement aims for Benuvia to utilize Bright Green's capabilities to produce Schedule I & II raw materials in compliance with regulatory standards, facilitating the manufacture of cGMP pharmaceutical-grade Active Pharmaceutical Ingredients for both US and global markets.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
